e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel molecular and genetic targets in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
L. Mur (Aberystwyth, United Kingdom)
Source:
International Congress 2017 – Novel molecular and genetic targets in COPD
Session:
Novel molecular and genetic targets in COPD
Session type:
Poster Discussion
Number:
375
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Mur (Aberystwyth, United Kingdom). Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases. 375
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
A new statistical diagnostic tool for respiratory diseases
Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Year: 2020
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013
Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019
Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The omics approach to defining endotypes and personalising treatment pathways in asthma
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021
Year: 2022
Molecular epidemiology of adverse respiratory effects: A high-throughput screening method to detect biomarkers of genotoxic exposure
Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates
Year: 2010
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Year: 2020
Integrating systems biology in respiratory diseases
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009
New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Overview and history of different ways of assessing and monitoring inflammatory airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015
Applying new respiratory function technologies to the elderly and the potential of future lung regeneration
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept